
Cyllene Therapeutics has raised €33m in Series C financing to support later-stage development of EG110A, an investigational genetic medicine for …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

